Kevin  Spain net worth and biography

Kevin Spain Biography and Net Worth

Director of Doximity
Mr. Spain has served as a member of our board of directors since March 2011. Since March 2011, Mr. Spain has served as general partner of Emergence Capital Partners, a venture capital firm, and served as a principal of Emergence Capital Partners from September 2006 to March 2011. Prior to joining Emergence Capital Partners, Mr. Spain was a member of the corporate development group of Microsoft Corporation, a computer software company, from June 2003 to May 2006, and a member of the corporate development group of Electronic Arts Inc., a game software content and services company, from September 2000 to May 2003. Mr. Spain was previously co-founder and chief executive officer of Madison.com, Inc., which provided a hosted marketing management solution for small and medium sized companies. Mr. Spain served on the board of directors of Veeva Systems Inc., or Veeva, a public cloud-computing company, from May 2008 to July 2014. Mr. Spain currently serves on the board of directors of several privately held companies. Mr. Spain holds a B.A. in Business Administration from the University of Texas at Austin and an M.B.A. from The Wharton School of the University of Pennsylvania.

How do I contact Kevin Spain?

The corporate mailing address for Mr. Spain and other Doximity executives is , , . Doximity can also be reached via phone at 650-549-4330 and via email at [email protected]. Learn More on Kevin Spain's contact information.

Has Kevin Spain been buying or selling shares of Doximity?

Kevin Spain has not been actively trading shares of Doximity in the last ninety days. Most recently, on Monday, June 28th, Kevin Spain bought 775,000 shares of Doximity stock. The stock was acquired at an average cost of $26.00 per share, with a total value of $20,150,000.00. Learn More on Kevin Spain's trading history.

Who are Doximity's active insiders?

Doximity's insider roster includes Anna Bryson (CFO), Timothy Cabral (Director), Paul Jorgensen (CRO), Joseph Kleine (Insider), Gilbert Kliman (Director), Craig Overpeck (Insider), Kevin Spain (Director), Kira Wampler (Director), and Phoebe Yang (Director). Learn More on Doximity's active insiders.

Are insiders buying or selling shares of Doximity?

In the last twelve months, insiders at the sold shares 12 times. They sold a total of 91,951 shares worth more than $2,844,642.74. The most recent insider tranaction occured on August, 9th when CFO Anna Bryson sold 30,000 shares worth more than $1,050,000.00. Insiders at Doximity own 37.4% of the company. Learn More about insider trades at Doximity.

Information on this page was last updated on 8/9/2024.

Kevin Spain Insider Trading History at Doximity

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/28/2021Buy775,000$26.00$20,150,000.00View SEC Filing Icon  
See Full Table

Kevin Spain Buying and Selling Activity at Doximity

This chart shows Kevin Spain's buying and selling at Doximity by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Doximity Company Overview

Doximity logo
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Read More

Today's Range

Now: $48.00
Low: $47.66
High: $50.14

50 Day Range

MA: $44.27
Low: $38.22
High: $61.25

2 Week Range

Now: $48.00
Low: $22.96
High: $61.75

Volume

2,675,242 shs

Average Volume

1,750,025 shs

Market Capitalization

$8.96 billion

P/E Ratio

55.17

Dividend Yield

N/A

Beta

1.3